Clinical Trial Update: Trial of Lenalidomide in Patients With Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT) Type [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating lenalidomide in patients with mucosa-associated lymphoid tissue lymphoma; current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucosa-associated Lymphoid Tissue Lymphoma

Drugs mentioned

• Revlimid (lenalidomide)

Snippet

Sponsor: Medical University of Vienna | Conditions: MALT Lymphoma | Phase 2 | Status: UNKNOWN